Hobbs Group Advisors’s Sanofi SNY Stock Holding History

Hobbs Group Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-146	Closed	-$8.41K	–	545
2024 Q3	$8.41K	Hold	146	–	–	﹤0.01%	440
2024 Q2	$7.08K	Buy	+146	New	+$7.04K	﹤0.01%	419

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hobbs Group Advisors's SNY Position: Q4 2024 in Review

Hobbs Group Advisors sold out of Sanofi (SNY) in Q4 2024, closing a stake of 146 shares — an estimated $8.41K sold.

Hobbs Group Advisors first reported a position in SNY in Q2 2024 and held it in 2 quarters. The position peaked at $8.41K in Q3 2024. 730 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

Hobbs Group Advisors reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
Hobbs Group Advisors sold 146 Sanofi shares in Q4 2024, an estimated $8.41K.
Hobbs Group Advisors first reported a position in Sanofi in Q2 2024 and held it in 2 quarters.
Hobbs Group Advisors's Sanofi position peaked at $8.41K in Q3 2024.
730 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Hobbs Group Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.